Last Updated: February 08, 2017
Last Updated: February, 2017
India is among the top 12 biotech destinations in the world and ranks second in Asia, after China. The Indian biotech industry is likely to experience significant growth on the back of increasing economic prosperity, health consciousness and a billion-plus population base. Current estimates value the industry at US$ 7 billion in FY15, which is expected to grow at 30.46 per cent Compound Annual Growth Rate (CAGR) to US$ 100 billion by FY25.
The sector is divided into five major segments: bio-pharma, bio-services, bio-agri, bio-industrial and bio-informatics. Biotechnology industry’s growth in India is primarily driven by vaccines and recombinant therapeutics. Going forward, India also has the potential to become a major producer of transgenic rice and several Genetically Modified (GM) or engineered vegetables.
As on November 2016, Odisha released the draft of its first Biotechnology policy. The state aims to become one of the top five bio-tech hubs in the country. The state government has proposed to set up a fund with investment of US$ 3.73 million and provide land on priority for setting up of biotechnology projects.
The Government of India has taken several initiatives including a biotechnology industry partnership program to develop new technologies and launched a National Rural Healthcare Mission to boost healthcare spending. As per the 12th Five-Year Plan, the government aims to spend US$ 3.7 billion on biotechnology compared to US$ 1.1 billion in the 11th Five-Year Plan to accelerate the pace of research, innovation and development. In addition, the Department of Biotechnology (DBT) has designed the National Biotechnology Development Strategy (NBDS) to strengthen the industry’s human resources and infrastructure while promoting growth and trade. Furthermore, the Government has allowed 100 per cent Foreign Direct Investment (FDI) through the automatic route for manufacturers of drugs and pharmaceuticals.
Download (Size: 1.46 MB )
Last Updated: February 08, 2017
The Indian biotechnology sector is expected to clock US$ 10 billion in revenue by 2015 on the back of emerging opportunities from around the world.
Powered by the Who's Who of India
Over 100 Indian companies participated at Arab Health 2017, the largest healthcare exhibition & medical congress in the Middle East and the second largest in the worl...
GST, the “most significant tax reform” so far in India is poised to enable India Inc to operate under a one-country one market philosophy. One of the biggest ...
The Government of India has laid special emphasis on the reforms required in its public procurement process. In a major step that aims to transform the way in which procu...
The provisions of the erstwhile Rajiv Awas Yojana (RAY) scheme weren’t the brightest idea because practical implementation, in scale, was not feasible, and hence it...
Organic farming has been witnessing rising popularity across markets, in tandem with the growing concerns related to intensive farming and an overdependence on agrochemi...
ICLP India has been helping major domestic and international brands to formulate and execute customer engagement strategies and drive loyalty programmes for over eight ye...
Cutlery You Can Eat
Narayana Peesapaty, a former researcher at the International Water Management Institute of Hyderabad, has created an innovative edible cutlery, mainly made out of sorghum. The basic idea behind the innovation - replace plastic spoons – struck Narayana during a flight, upon observing fellow passengers..